148579-57-1

Basic information

• Product Name: (2S,3R,4S,5S,6S)-2-(4-(hydroxymethyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
• Synonyms: (2S,3R,4S,5S,6S)-2-(4-(hydroxymethyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
• CAS NO: 148579-57-1
• Molecular Weight: 440.404
• Mol File: 148579-57-1.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: (2S,3R,4S,5S,6S)-2-(4-(hydroxymethyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3R,4S,5S,6S)-2-(4-(hydroxymethyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate(148579-57-1)
• EPA Substance Registry System: (2S,3R,4S,5S,6S)-2-(4-(hydroxymethyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate(148579-57-1)

Safety Data

• Hazardous Substances Data: 148579-57-1(Hazardous Substances Data)

Upstream product

• 123-08-0 4-hydroxy-benzaldehyde 
• 6919-98-8 2,3,4-tri-O-acetyl-1-bromo-1-deoxy-β-D-glucopyranuronic acid methy ester 
• 92420-85-4 4-(methyl)phenyl-beta-D-glucopyranosiduronic acid methyl ester tetraacetate 
• 7355-18-2 (2S,3S,4S,5R,6S)-3,4,5,6-Tetraacetoxy-tetrahydro-pyran-2-carboxylic acid methyl ester 
• 82228-14-6 methyl D-glucopyranuronate 
• 148579-55-9 (2S,3S,4S,5R,6S)-3,4,5-Triacetoxy-6-(4-bromomethyl-phenoxy)-tetrahydro-pyran-2-carboxylic acid methyl ester 
• 148579-56-0 (2S,3R,4S,5S,6S)-2-(4-formylphenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 21085-72-3 1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester 
• 32449-92-6 D-glucurono-6,3-lactone 

Downstream Products

• 1349833-42-6 methyl (2S,3S,4S,5R,6S)-3,4,5-triacetoxy-6-(4-((4-formylphenylcarbamoyloxy)methyl)phenoxy)-tetrahydro-2H-pyran-2-carboxylate 
• 1349833-43-7 methyl (2S,3S,4S,5R,6S)-3,4,5-triacetoxy-6-(4-((4-((3,7-dimethyloct-6-enyloxy)(phenethoxy)methyl)phenylcarbamoyloxy)-methyl)phenoxy)tetrahydro-2H-pyran-2-carboxylate 
• 1349833-44-8 lithium (2S,3S,4S,5R,6S)-6-(4-((4-((3,7-dimethyloct-6-enyloxy)(phenethoxy)methyl)phenylcarbamoyloxy)-methyl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate 
• 1373332-70-7 (2S,3S,4S,5R,6S)-6-(4-((4-(difluoromethyl)phenylcarbamoyloxy)methyl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid 
• 1373332-71-8 (2S,3R,4S,5S,6S)-2-(4-((4-(difluoromethyl)phenylcarbamoyloxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 200722-83-4 C₂₈H₃₉Cl₄N₂O₁₂P 

Relevant articles and documents

PYRROLOBENZODIAZEPINE DIMER PRECURSOR AND LIGAND-LINKER CONJUGATE COMPOUND THEREOF

The present invention relates to a pyrrolobenzodiazepine dimer prodrug and a ligand-linker conjugate compound thereof, a composition containing these, and therapeutic use thereof particularly as an anticancer drug. The stability of the compounds themselves and the stability thereof in plasma are excellent and the compounds are advantageous in terms of manifestation of toxicity, and thus the compounds are industrially useful in that it is possible to target proliferative diseases such as cancer, to perform a specific treatment, to maximize the drug efficacy, and to minimize the occurrence of side effects.

Extended scaffold glucuronides: En route to the universal synthesis of O -aryl glucuronide prodrugs

We demonstrate that an extended scaffold based on a self-immolative linker (SIL) enables the universal production of O-aryl glucuronide prodrugs: high yield glucuronidation is performed on a precursor substrate (SIL) and the subsequent drug conjugation proceeds via less challenging chemical reactions.

CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF

The present invention is directed to novel calicheamicin derivatives useful as payloads in antibody-drug-conjugates (ADC's), and to payload-linker compounds and ADC compounds comprising the same; to pharmaceutical compositions comprising the same and to methods for using the same to treat pathological conditions such as cancer.